
51 - 200 funcionários
Fundada em 2016
🏥 Saúde
💼 Consultoria
⚖️ Jurídico
Healthcare • Consulting • Legal
A Immunic Therapeutics é uma empresa de biotecnologia em estágio avançado, focada no desenvolvimento de novas terapias de moléculas pequenas, administradas por via oral, para doenças inflamatórias crônicas e autoimunes, com programas específicos direcionados à esclerose múltipla e doença celíaca. A empresa avança com programas diferenciados em estágio clínico (ex. : vidofludimus calcium, IMU-856, IMU-381) visando fornecer opções de tratamento oral eficazes, seguras e bem toleradas para condições neurológicas e gastrointestinais mediadas pelo sistema imunológico, enquanto busca proteções regulatórias e caminhos para comercialização.
🕒 Outubro 29
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $230.000 - $270.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 5%
🗣️🇺🇸🇬🇧 Inglês obrigatório
De onde vem esta vaga
Publicada na página de carreiras da Immunic Therapeutics, não em um site de vagas
Vista pela primeira vez pelo Remote Rocketship Outubro 29
Ainda aberta no site da Immunic Therapeutics. Verificada 1 hora atrás.

51 - 200 funcionários
Fundada em 2016
🏥 Saúde
💼 Consultoria
⚖️ Jurídico
Healthcare • Consulting • Legal
A Immunic Therapeutics é uma empresa de biotecnologia em estágio avançado, focada no desenvolvimento de novas terapias de moléculas pequenas, administradas por via oral, para doenças inflamatórias crônicas e autoimunes, com programas específicos direcionados à esclerose múltipla e doença celíaca. A empresa avança com programas diferenciados em estágio clínico (ex. : vidofludimus calcium, IMU-856, IMU-381) visando fornecer opções de tratamento oral eficazes, seguras e bem toleradas para condições neurológicas e gastrointestinais mediadas pelo sistema imunológico, enquanto busca proteções regulatórias e caminhos para comercialização.
• Establish and lead Immunic's HEOR capability within Medical Affairs • Develop and maintain a prioritized, multi-year HEOR and value-evidence strategy for vidofludimus calcium • Lead evidence-gap assessments and translate gaps into research questions, study concepts, investment recommendations, and decision points • Partner on Immunic's real-world evidence strategy, including MS registry engagement, commercial real-world data sources, and data-use agreements • Prioritize RWE research questions and represent HEOR in registry consortia and real-world data networks • Design and oversee HEOR and outcomes research, including burden-of-illness, epidemiology, treatment-pattern, patient-reported outcomes/quality-of-life, and economic-modeling studies • Develop budget-impact and cost-effectiveness models for payer, reimbursement, and HTA discussions • Integrate HEOR priorities into evidence-generation and publication strategies • Ensure studies and analyses are rigorous, documented, balanced, and transparent about assumptions, limitations, and uncertainty • Partner with clinical, biostatistics, regulatory, medical affairs, and other teams on outcomes, endpoints, patient-reported measures, and evidence-generation opportunities • Provide payer, HTA, patient, and healthcare-system perspectives during protocol development, analysis planning, and data interpretation • Partner with Market Access on payer and HTA evidence needs, value dossiers, evidence summaries, and related models • Represent HEOR in cross-functional program and launch-readiness forums • Build relationships with external HEOR experts, academic collaborators, research networks, payers, HTA experts, and MS-focused thought leaders • Translate external insights into HEOR hypotheses and research priorities • Communicate complex economic and outcomes concepts to audiences with varying technical expertise • Establish HEOR governance, planning, and decision-making processes • Select and direct external research partners while maintaining internal ownership of strategy, quality, and deliverables • Develop and manage the HEOR budget and resourcing model • Establish measures of progress and impact for the HEOR function
• At least eight years of progressive HEOR, outcomes research, RWE, or related evidence-generation experience in the biopharmaceutical industry, or six years with a PhD, PharmD, or MD • Experience developing or leading an integrated HEOR/value-evidence strategy • Experience supporting late-stage development, launch readiness, or lifecycle evidence generation • Advanced degree in health economics, outcomes research, epidemiology, health services research, public health, pharmacy, medicine, or a related quantitative or clinical discipline preferred • Strong knowledge of HEOR research methods • Hands-on experience designing, critically evaluating, or overseeing economic models and evidence-generation studies • Familiarity with registry-, claims-, or EHR-based real-world evidence research • Working knowledge of the US payer landscape • Familiarity with global HTA evidence requirements • Experience directing external research partners and managing scope, budget, timelines, scientific quality, and deliverables • Strong written and verbal communication skills • Comfort operating in a smaller, pre-commercial biotech environment with shifting priorities • Demonstrated ability to influence cross-functional stakeholders and drive decisions without formal authority • Must be authorized to work in the US
• Equity • Bonus • Remote work arrangement
Candidatar-seMelhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.
🕒 Outubro 29
Director leading revenue-cycle analytics for Surgery Partners’ ambulatory surgery centers, hospitals, and corporate teams. Driving KPI governance, executive dashboards, root-cause analysis, and performance improvement.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 29
Director building virtual HCP engagement for Mineralys Therapeutics’ hypertension and kidney-disease medicines. Launching and leading remote sales coverage across open territories.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $180.000 - $215.000 / ano
🔥 Investimento no último ano
💰 $500.000.000 Post-IPO Debt em 2026-06
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 29
Illumina director leading global market access for oncology genomic diagnostics. Shaping reimbursement, evidence, payer engagement, and commercialization strategies worldwide.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $205.100 - $307.700 / ano
💰 $750.000.000 Post-IPO Debt em 2023-01
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 29
Director of Research shaping strategic healthcare insights for Chartis, a healthcare consulting firm. Developing thought leadership, market perspectives, and data systems supporting firm growth.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $110.000 - $150.000 / ano
💰 Private Equity Round em 2012-12
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 29
Director leading commercial data, advanced analytics, and forecasting at REGENXBIO, a gene therapy company. Building launch-readiness models, forecasts, dashboards, and decision-support capabilities.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $196.000 - $265.000 / ano
🔥 Investimento no último ano
💰 $100.000.000 Post-IPO Equity em 2026-07
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório